InvestorsHub Logo
Followers 2
Posts 353
Boards Moderated 0
Alias Born 07/13/2007

Re: biotech2010 post# 2452

Tuesday, 09/27/2016 6:23:06 PM

Tuesday, September 27, 2016 6:23:06 PM

Post# of 3834
A couple things, i think I'll email IR too

1) maybe we get some Melanoma data that helps at some point, though timing is unclear
2) if it showed no fibrosis benefit how could it show Cirrhosis if that is in effect a more severe more of fibrosis (scarring), i would think that is a gradual reversal process so that fact it wasn't working after 30% of the equivalent CX doses why would they possibly believe it suddenly would start to. It makes me believe they are wasting a lot of people's time, albeit, some are getting paid nicely during this.
3) somewhat baffled cohort 3 showed some benefit on only 4 doses and phase 2 shows none with 9
4) did they indicate if any of the warrants were execute last week or they did any AMT to generate some funds

Have to really question if this really provides any benefit.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News